Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 121

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Impact of Curcumin-Induced Changes in P-Glycoprotein and CYP3A Expression on the Pharmacokinetics of Peroral Celiprolol and Midazolam in Rats

Zhang, Wenxia, Tan, Theresa May Chin, Lim, Lee-Yong·2007·Drug Metabolism and Disposition
DOI 10.1124/dmd.106.011072
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1124/dmd.106.011072

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 39

  1. Ammon, 1991, Pharmacology of Curcuma longa, Planta Med, 57, 1, 10.1055/s-2006-960004 · DOI · Paper page
  2. Anuchapreeda, 2002, Modulation of P-glycoprotein expression and function by curcumin in multidrug resistant human KB cells, Biochem Pharmacol, 64, 573, 10.1016/S0006-2952(02)01224-8 · DOI · Paper page
  3. Caudron, 2004, Simultaneous determination of the acid/base antihypertensive drugs celiprolol, bisoprolol and irbesartan in human plasma by liquid chromatography, J Chromatogr B Analyt Technol Biomed Life Sci, 801, 339, 10.1016/j.jchromb.2003.11.009 · DOI
  4. Chaobal, 2005, Single-point sampling for assessment of constitutive, induced, and inhibited cytochrome P450 3A activity with alfentanil or midazolam, Clin Pharmacol Ther, 78, 529, 10.1016/j.clpt.2005.08.004 · DOI
  5. Cheng, 2001, Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions, Anticancer Res, 21, 2895
  6. Cornaire, 2004, Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo, Int J Pharm (Amst), 278, 119, 10.1016/j.ijpharm.2004.03.001 · DOI · Paper page
  7. Cruz-Correa, 2006, Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis, Clin Gastroenterol Hepatol, 4, 1035, 10.1016/j.cgh.2006.03.020 · DOI · Paper page
  8. Doherty, 1977, Pharmacokinetics of digoxin, Fed Proc, 36, 2242
  9. Dresser, 2003, Coordinate induction of both cytochrome P4503A and MDR1 by St. John’s wort in healthy subjects, Clin Pharmacol Ther, 73, 41, 10.1067/mcp.2003.10 · DOI · Paper page
  10. Dürr, 2000, St. John’s wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4, Clin Pharmacol Ther, 68, 598, 10.1067/mcp.2000.112240 · DOI · Paper page
  11. Galetin, 2005, CYP3A4 substrate selection and substitution in the prediction of potential drug-drug interactions, J Pharmacol Exp Ther, 314, 180, 10.1124/jpet.104.082826 · DOI
  12. Greiner, 1999, The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin, J Clin Investig, 104, 147, 10.1172/JCI6663 · DOI
  13. Gurley, 2006, Effect of milk thistle (Silybum marianum) and black cohosh (Cimicifuga racemosa) supplementation on digoxin pharmacokinetics in humans, Drug Metab Dispos, 34, 69, 10.1124/dmd.105.006312 · DOI
  14. Hartmann, 2005, Impact of endotoxin-induced changes in P-glycoprotein expression on disposition of doxorubicin in mice, Drug Metab Dispos, 33, 820, 10.1124/dmd.104.002568 · DOI
  15. Ireson, 2002, Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine, Cancer Epidemiol Biomarkers Prev, 11, 105
  16. Johne, 1999, Pharmacokinetic interaction of digoxin with an herbal extract from St. John’s wort (Hypericum perforatum), Clin Pharmacol Ther, 66, 338, 10.1053/cp.1999.v66.a101944 · DOI · Paper page
  17. Kanazu, 2005, Assessment of the hepatic and intestinal first-pass metabolism of midazolam in a CYP3A drug-drug interaction model rats, Xenobiotica, 35, 305, 10.1080/00498250500093786 · DOI
  18. Karlsson, 1993, Transport of celiprolol across human intestinal epithelial (Caco-2) cells: mediation of secretion by multiple transporters including P-glycoprotein, Br J Pharmacol, 110, 1009, 10.1111/j.1476-5381.1993.tb13914.x · DOI
  19. Kim, 1999, Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein, Pharm Res (NY), 16, 408, 10.1023/A:1018877803319 · DOI · Paper page
  20. Kotegawa, 2002, In vitro, pharmacokinetic, and pharmacodynamic interactions of ketoconazole and midazolam in the rat, J Pharmacol Exp Ther, 302, 1228, 10.1124/jpet.102.035972 · DOI
  21. Kronbach, 1989, Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4, Mol Pharmacol, 36, 89, 10.1016/S0026-895X(25)09118-7 · DOI · Paper page
  22. Lilja, 2003, Itraconazole increases but grapefruit juice greatly decreases plasma concentrations of celiprolol, Clin Pharmacol Ther, 73, 192, 10.1067/mcp.2003.26 · DOI
  23. Liu, 2006, Human pregnane X receptor-mediated transcriptional regulation of cytochrome P450 3A4 by some phytochemicals, Zhejiang Da Xue Xue Bao Yi Xue Ban, 35, 8
  24. Lown, 1994, Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test, Drug Metab Dispos, 22, 947, 10.1016/S0090-9556(25)08440-5 · DOI
  25. Lown, 1997, Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine, Clin Pharmacol Ther, 62, 248, 10.1016/S0009-9236(97)90027-8 · DOI
  26. Luo, 2003, Concurrent induction and mechanism-based inactivation of CYP3A4 by an L-valinamide derivative, Drug Metab Dispos, 31, 1170, 10.1124/dmd.31.9.1170 · DOI
  27. Mai, 2004, Hyperforin content determines the magnitude of the St John’s wort-cyclosporine drug interaction, Clin Pharmacol Ther, 76, 330, 10.1016/j.clpt.2004.07.004 · DOI
  28. Mountfield, 2000, Potential inhibitory effects of formulation ingredients on intestinal cytochrome P450, Int J Pharm (Amst), 211, 89, 10.1016/S0378-5173(00)00586-X · DOI
  29. Pruss, 1988, Celiprolol— overview of 6 years of clinical trials experience, J Int Med Res, 16, 17A
  30. Ravindranath, 1980, Absorption and tissue distribution of curcumin in rats, Toxicology, 16, 259, 10.1016/0300-483X(80)90122-5 · DOI · Paper page
  31. Sharma, 2004, Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance, Clin Cancer Res, 10, 6847, 10.1158/1078-0432.CCR-04-0744 · DOI · Paper page
  32. Sharma, 2001, Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer, Clin Cancer Res, 7, 1894
  33. Synold, 2001, The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux, Nat Med, 7, 584, 10.1038/87912 · DOI
  34. ter Horst, 2003, Simultaneous determination of levomepromazine, midazolam and their major metabolites in human plasma by reversed-phase liquid chromatography, J Chromatogr B Analyt Technol Biomed Life Sci, 791, 389, 10.1016/S1570-0232(03)00253-8 · DOI
  35. Tindle, 2005, Trends in use of complementary and alternative medicine by US adults: 1997–2002, Altern Ther Health Med, 11, 42
  36. Wacher, 1995, Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy, Mol Carcinog, 13, 129, 10.1002/mc.2940130302 · DOI
  37. Warrington, 2004, The effect of age on P-glycoprotein expression and function in the Fischer-344 rat, J Pharmacol Exp Ther, 309, 730, 10.1124/jpet.103.061234 · DOI
  38. Yasuda, 2002, Interaction of cytochrome P450 3A inhibitors with P-glycoprotein, J Pharmacol Exp Ther, 303, 323, 10.1124/jpet.102.037549 · DOI
  39. Zhang, 2003, Commonly used surfactant, Tween 80, improves absorption of P-glycoprotein substrate, digoxin, in rats, Arch Pharm Res (NY), 26, 768, 10.1007/BF02976689 · DOI

Cited by

Metadata

Authors
Zhang, W., Tan, T. M. C., & Lim, L.-Y.
Venue
Drug Metabolism and Disposition
Publisher
Elsevier BV
Published
2007-01
Volume
35
Issue
1
Pages
110-115
ISSN
0090-9556
DOI
10.1124/dmd.106.011072
Cited by
121
References
1
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.